Pearls for Atopic Dermatitis Management
Experts in dermatology share practice pearls and takeaways for treatment of atopic dermatitis.
Read More
Patient Adherence in Atopic Dermatitis
Expert dermatologists discuss treatment discontinuation as a barrier to achieving desired outcomes in atopic dermatitis.
Use of Tralokinumab in Atopic Dermatitis
Aaron S. Farberg, MD, comments on use of different treatments for atopic dermatitis when a patient does not respond to treatment.
Impact of Dupilumab on Quality of Life for Atopic Dermatitis Patients
Expert dermatologists review the positive impact dupilumab has on quality of life for a patient with atopic dermatitis.
Efficacy and Reported Outcomes With JAK Inhibitors in Atopic Dermatitis
Experts in dermatology discuss efficacy and patient-reported outcomes of topical and systemic JAK inhibitors and dosing guidelines in atopic dermatitis.
Ideal Candidates for Ruxolitinib Treatment of Atopic Dermatitis
Matthew Zirwas, MD, provides insight into the ideal candidates for use of ruxolitinib to treat atopic dermatitis, focusing on patients with sensitive skin.
Safety Profile of Topical Ruxolitinib in Atopic Dermatitis
Expert dermatologists review the safety data of topical ruxolitinib in the treatment of atopic dermatitis.
Clinical Trials of Topical Ruxolitinib in Atopic Dermatitis
Alexandra Golant, MD, highlights the positive clinical data of ruxolitinib, a topical JAK inhibitor used for the treatment of atopic dermatitis.
Overview of JAK Inhibitors in Atopic Dermatitis
Peter A. Lio, MD, provides an overview of emerging JAK inhibitors in the treatment of atopic dermatitis.
Assessing Severity of Atopic Dermatitis
Experts in dermatology consider the use of the Atopic Dermatitis Control Tool and other tools to assess severity of atopic dermatitis.
Treatment Approach to Atopic Dermatitis
Aaron S. Farberg, MD, discusses how new therapies have impacted his approach to treatment of atopic dermatitis.
Traditional Steroids vs Emerging Therapies in Atopic Dermatitis
Alexandra Golant, MD, comments on the adverse events of systemic therapies and how emerging nonsteroidal agents have a better safety profile in atopic dermatitis.
Treatment Landscape in Atopic Dermatitis
Matthew Zirwas, MD, highlights therapies that are available for the treatment of atopic dermatitis, including corticosteroids, calcineurin inhibitors and JAK inhibitors.
The Impact of Atopic Dermatitis on Quality of Life
Expert dermatologists review the impact of atopic dermatitis on quality of life for both the patient and their families.
An Overview of Atopic Dermatitis (AD)
Peter A. Lio, MD, provides an overview of the pathophysiology of atopic dermatitis (AD) and the comorbidities often associated with it.